{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"hyper-beta-alaninemia","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"Hyperbetaalaninemia is a very rare metabolic condition. Hyperbetaalaninemia refers to the build-up of beta amino acids in the body. The excess beta amino acids are neurotoxic to the body. Signs and symptoms of Hyperbetaalaninemia include convulsions (rapid and uncontrollable shaking), lethargy, and encephalopathy. Hyperbetaalaninemia is thought to be due to a loss of a functional form of the enzyme, beta-alanine-alpha-ketoglutarate transaminase.","mondoId":"MONDO:0009378","node":{"canonicalSlug":"hyper-beta-alaninemia","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Hyper-beta-alaninemia","originalSourceId":"ORPHA:309147","paragraphs":["Hyperbetaalaninemia is a very rare metabolic condition. Hyperbetaalaninemia refers to the build-up of beta amino acids in the body. The excess beta amino acids are neurotoxic to the body. Signs and symptoms of Hyperbetaalaninemia include convulsions (rapid and uncontrollable shaking), lethargy, and encephalopathy. Hyperbetaalaninemia is thought to be due to a loss of a functional form of the enzyme, beta-alanine-alpha-ketoglutarate transaminase."],"rawAttribution":"MONDO:0009378","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:41:04Z","upstream":"GARD:0010267","url":"https://rarediseases.info.nih.gov/diseases/10267"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"inborn disorder of pyrimidine metabolism","mondoId":"MONDO:0019238","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published","editorialReview":{"reviewedAt":"2026-10-26","decision":"corrected","reason":"Remove the inaccurate protein-building-block description of beta amino acids.","sources":["https://www.ncbi.nlm.nih.gov/medgen/866733"],"originalNarrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Hyper-beta-alaninemia","originalSourceId":"ORPHA:309147","paragraphs":["Hyperbetaalaninemia is a very rare metabolic condition. Hyperbetaalaninemia refers to the build-up of protein building blocks, called beta amino acids, in the body. The excess beta amino acids are neurotoxic to the body. Signs and symptoms of Hyperbetaalaninemia include convulsions (rapid and uncontrollable shaking), lethargy, and encephalopathy. Hyperbetaalaninemia is thought to be due to a loss of a functional form of the enzyme, beta-alanine-alpha-ketoglutarate transaminase."],"rawAttribution":"MONDO:0009378","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:41:04Z","upstream":"GARD:0010267","url":"https://rarediseases.info.nih.gov/diseases/10267"},"claimHolds":[]}},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/10267\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0009378\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0010267</dd></dl></details><p class=\"section-source\">Source clarification. <a href=\"https://www.ncbi.nlm.nih.gov/medgen/866733\" rel=\"noreferrer\">1</a></p>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Hyperbetaalaninemia is a very rare metabolic condition. Hyperbetaalaninemia refers to the build-up of beta amino acids in the body. The excess beta amino acids are neurotoxic to the body. Signs and symptoms of Hyperbetaalaninemia include convulsions (rapid and uncontrollable shaking), lethargy, and encephalopathy. Hyperbetaalaninemia is thought to be due to a loss of a functional form of the enzyme, beta-alanine-alpha-ketoglutarate transaminase.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/10267\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"hyper-beta-alaninemia","sourceDocuments":[{"name":"GARD: Hyper-beta-alaninemia","reviewed":null,"source_release":"2026-10-25T03:41:04Z","url":"https://rarediseases.info.nih.gov/diseases/10267"},{"name":"MONDO: hyper-beta-alaninemia","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0009378"}],"sourceNote":"","synonyms":["hyper-beta-alaninemia","hyperalaninemia","hyperbetaalaninemia"],"takeawayHtml":"","title":"hyper-beta-alaninemia"},"schemaVersion":1}
